The Genomic Landscape of the Fungus-Specific SWI/SNF Complex Subunit, Snf6, in Candida albicans

Candida albicans is a natural component of the human microbiota but also an opportunistic pathogen that causes life-threatening infections in immunosuppressed patients. Current therapeutics include a limited number of molecules that suffer from limitations, including growing clinical resistance and toxicity. New molecules are being clinically investigated; however, the majority of these potential antifungals target the same processes as do the standard antifungals and might confront the same problems of toxicity and loss of efficiency due to the common resistance mechanisms. Here, we characterized the role of Snf6, a fungus-specific subunit of the chromatin-remodeling complex SWI/SNF. Our genomic and phenotypic data demonstrated a central role of Snf6 in biological processes that are critical for a fungal pathogen to colonize its host and cause disease, suggesting Snf6 as a possible antifungal target.

C andida albicans is a normal commensal of humans that can become a potentially life-threatening fungal pathogen in immunosuppressed patients. Systemic infections resulting from C. albicans are associated with mortality rates of 50% or greater despite currently available antifungal therapies (1)(2)(3). There are presently a limited number of antifungal molecules and drug targets due to the eukaryotic nature of fungi, which makes them similar to their hosts and complicates the targeting of processes that are intrinsically associated with the fungus, and also due to rising cases of resistance. Currently, many new molecules are being preclinically or clinically investigated; however, the majority of those potential antifungals target the same processes as do the standard antifungals and would likely confront the same problems of toxicity and loss of efficiency due to the common resistance mechanisms (4). Hence, an antifungal agent with a new mechanism of action would be advantageous for treatment of fungal infections.
SWI/SNF is an ATP-dependent chromatin-remodeling complex required for the regulation of gene expression in eukaryotes (5). Through its catalytic subunit Snf2, SWI/SNF promotes ATP-dependent nucleosome repositioning by sliding nucleosomes on DNA or evicting histones to allow the binding of transcription factors to their promoters (5). In the yeast Saccharomyces cerevisiae, SWI/SNF sliding/eviction activity was found to be required for the binding of different transcriptional regulators, such as Gal4, Hap4, and Gcn4, to allow activation of their target genes (6,7). The yeast SWI/SNF controls the mRNA levels of a limited set of genes (2 to 5% of all yeast genes), suggesting a specific functional regulation (8). Recent studies have shown that the SWI/SNF complex exhibits structural modularity (subcomplexes) that can differentially regulate the expression of different sets of genes (9,10). For instance, under the same growth conditions, the transcript levels of genes for ribosome biogenesis and rRNA processing in S. cerevisiae were downregulated in an snf2 mutant strain but not in an snf5 strain. Similarly, transcripts of sulfur metabolism and glycolysis were upregulated in the snf2 but not in the snf5 strain. These results suggest that even if Snf2 and Snf5 are components of the same complex, they have a differential contribution to gene expression control (9).
In C. albicans, both Snf2 and Swi1 subunits were shown to be essential for proper differentiation of invasive hyphae as well as virulence in a mouse model of systemic infection (11). Recently, the SWI/SNF complex was found to control the expression of the major facilitator transporter Mdr1, which mediates azole resistance in C. albicans. Occupancy of the transcriptional activator Mrr1 to the promoter of the Mdr1 transporter gene was completely dependent on the nucleosome sliding activity of Snf2 (12). Interestingly, genetic inactivation of SNF2 in azole-resistant strains with an MRR1 gain-of-function mutation significantly sensitizes the cells to fluconazole (12). Taken together, small molecules targeting this complex could provide a dual action by both abolishing C. albicans virulence and restoring azole sensitivity to resistant strains. However, given the conservation of this chromatin-remodeling complex in humans, inhibitors of the C. albicans SWI/SNF might also alter the function of its host counterpart.
In addition to the catalytic subunit, Snf2, SWI/SNF is made up of 11 subunits in yeast and C. albicans (13,14). While most members of the fungal SWI/SNF complex are conserved with the metazoan SWI/SNF, subunits including Snf6, Snf11, Taf14, and Swp82 are specific to fungi (13). Since SWI/SNF is a potential antifungal target, chemical perturbation of specific fungal subunits would be a good approach to avoid crossinteraction with human SWI/SNF activity. Here, we have focused our investigation on the characterization of the role of the fungus-specific SWI/SNF subunit, Snf6. Our data show that, although the C. albicans subunit has only limited sequence similarity to other fungal orthologs, Snf6 was copurified with SWI/SNF complex subunits including the catalytic ATPase subunit, Snf2. We show that Snf6 plays a critical role in biological processes that are essential for fungal pathogenesis, including carbon metabolic flexibility, stress response, and morphogenesis. The Snf6 regulon was determined by combining both genome-wide location (chromatin immunoprecipitation with microar-ray technology [ChIP-chip]) and transcriptional profiling (microarrays) to identify targets of the SWI/SNF complex under both yeast-and hypha-promoting conditions.

RESULTS
The ORF C2_03930C_A encodes the SWI/SNF fungus-specific subunit, Snf6. We used Candida glabrata Snf6 (CgSnf6) (15) as a query to identify the C. albicans Snf6 homolog using BLAST analysis. Our search returned the open reading frame (ORF) C2_03930C_A as a sole hit with 35% identity to CgSnf6. With the exception of a small N-terminal region (positions 58 to 101), the Snf6 protein sequence was not well conserved among the ascomycetes (Fig. 1A). Further, using the CGD alignment function, we looked for the orthologs of the ORF C2_03930C_A in the Candida clade and got a set of alignments that identified the region that was most similar among the species. To confirm that C2_03930C_A is the bona fide C. albicans Snf6 (CaSnf6), we used tandem affinity purification (TAP) to comprehensively characterize the Snf6-containing protein complex. Snf6 complexes were affinity purified from log-phase C. albicans cultures growing in rich medium (yeast extract-peptone-dextrose [YPD]) using a TAPtagged Snf6 subunit, and protein interactors were identified using mass spectrometry (MS) from in-solution-digested trichloroacetic acid (TCA)-precipitated proteins or SDS-PAGE gel bands. In total, 116 proteins were identified, including 9 proteins that are known SWI/SNF complex subunits ( Fig. 1B; also see Table S1 in the supplemental material). This includes the ATPase catalytic subunit, Snf2, in addition to Snf5, Snf12, Swi1, Swi3, Arp2, Arp7, Arp9, and Act1. In accordance with its role in transcriptional control, Snf6 also copurified with proteins related to general transcriptional machinery, such as RNA polymerases I (Rpa190) and II (Rpo21 and Rpb2), the mediator complex (subunits Med14 and Med18), and the core histone protein, Htb2. Interestingly, Snf6 interacted with the Snf2 homolog, Sth1, which is the catalytic subunit of the essential RSC (Remodel the Structure of Chromatin) complex. This suggests that both SWI/SNF and RSC chromatin remodelers may cooperate to modulate gene expression in C. albicans. Snf6 interactors were also enriched in functions related to the proteasome and protein catabolism in addition to vesicle trafficking (Fig. 1B). Coimmunoprecipitation was used to confirm the interaction of Snf6 with two SWI/SNF subunits, Snf2 and Swi1 (Fig. 1C).
Snf6 is required for both activation and repression of its target genes. When strains were serially diluted and grown on plates under standard repressing conditions (YPD plus 20 g/ml doxycycline) for 3 days at 30°C, there was little effect on growth (Fig. 3A). However, the repression of the SNF6 gene influenced cell and colony morphology; the mutant grew as chains of ellipsoid cells in a budding pattern with branches at 30°C. To relate the genomic occupancy of Snf6 to its role in regulating gene expression, transcriptional profiling of snf6/Tet-SNF6, the conditional GRACE mutant (16), was performed using microarrays. Snf6-dependent transcripts were identified by comparing the transcriptional profile of snf6/Tet-SNF6 cells treated with doxycycline to that of nontreated snf6/Tet-SNF6 cells. A total of 128 transcripts were differentially regulated, including 57 upregulated and 69 downregulated genes (Table S3). Transcripts that Snf6 failed to repress (upregulated in the mutant) were mainly enriched in functions related to carbohydrate metabolism and stress response (Fig. 2B). Gene ontology (GO) analysis of transcripts that require Snf6 for their activation (downregulated in the mutant) did not give any statistically significant functional enrichment of GO terms. However, a careful analysis of the list of downregulated genes uncovered transcripts associated with cell wall biosynthesis (SMI1 and C1_14060W_A), glucose transport (HGT1 and HGT19), adhesion (CSH1, SAP9, and ALS4), and vesicle transport (ALY2, VRP1, and SEC2).
To further investigate the C. albicans cellular pathways whose expression is influenced by inactivation of SNF6, we performed gene set enrichment analysis (GSEA). Within the set of genes upregulated in the snf6 mutant, GSEA detected enrichment for genes downregulated in the yeast efg1 and tye7 mutants and genes upregulated in Spider-medium-generated hyphal cells and in Ada2 and Gal4 transcription factor binding (Table S3). In the set of downregulated genes in the snf6 mutant, the GSEA showed enrichment of SWI4/SWI6 downregulated genes, genes downregulated in Spider-medium-generated hyphal cells, genes suppressed by heat shock, and ribosome genes and a correlation with Tbf1, Fhl1, and Ifh1 transcription factor binding, suggesting that the regulation of the ribosomal protein regulon has been compromised (Table S3). By overlapping the ChIP-chip data with the list of Snf6 transcriptionally dependent genes, we identified 28 direct Snf6 targets including 15 upregulated and 13 downregulated transcripts (Fig. 2C). These data suggest that Snf6 contributes to both activation and repression of its target genes. Glycolytic genes, in addition to genes for heat shock proteins, were among genes that Snf6 represses directly, while genes that depend on Snf6 for their direct activation belong to diverse metabolic processes ( Fig. 2C; Table S3).
Snf6 is required for carbon utilization, hyphal and invasive growth, and resistance to heat stress. Since Snf6 binds directly to the promoters of genes related to carbohydrate metabolism and it is required for their proper modulation, we wanted to assess whether it is essential for growth flexibility in media with different carbon sources including fermentable alternative sugars (glucose, fructose, galactose, and mannose) and nonfermentable carbon (glycerol). While no discernible growth defect was observed on glucose, snf6 strains exhibited a severe growth defect especially when growing in medium with galactose or glycerol as a sole source of carbon (Fig. 3B). This suggests that, as in S. cerevisiae (17), Snf6 is required for metabolic flexibility of carbon use.
Carbon limitation or poor carbon sources are well-known cues that promote the switch of C. albicans cells from the yeast to the hyphal state (18). Also, carbohydrate WT and snf6/Tet-SNF6 cells were serially diluted and grown on plates under nonrepressing (YPD) or standard repressing (YPD plus 20 g/ml doxycycline) conditions for 3 days at 30°C, and the resulting colonies were photographed. Cells from snf6 mutant colonies were observed by microscopy using differential interference contrast for bright field or through the 4=,6-diamidino-2-phenylindole (DAPI) filter for calcofluor white staining. (B) WT and snf6/Tet-SNF6 cells were grown in different solid media with different carbon sources under both repressing (40 g/ml doxycycline) and nonrepressing conditions. Pictures were taken after 3 days of growth. WT refers to strain CAI4. (C) Snf6 is required for hyphal development. WT and snf6/Tet-SNF6 cells were grown in YPD plus 10% FBS and Spider and M199 media to promote invasive hypha formation in the presence or the absence of doxycycline. Representative pictures were taken after 3 days of growth. utilization genes are coactivated during the yeast-to-hypha transition (19,20). Since snf6 mutant strains exhibited growth defects in different carbon sources, we wanted to test whether this SWI/SNF subunit is required for hyphal formation in response to different cues. The ability of the snf6 conditional mutant to form hyphae was assessed using fetal bovine serum (FBS) or Spider or M199 medium or alkaline pH. Wild-type (WT) and snf6/Tet-SNF6 strains nontreated with doxycycline formed abundant filaments at the edge of colonies and exhibited a typical wrinkled-colony morphology (Fig. 3C). In contrast, snf6/Tet-SNF6 cells under repressible conditions did not develop invasive filaments, and microscopic analysis of cells from colonies showed swollen yeast cells that form chains (Fig. 3C and 4B).
Since Snf6 also bound directly to heat shock proteins and was required for their activation, we tested the ability of an snf6 conditional mutant to grow at high temperatures. Our data revealed that, under repressible conditions, snf6 mutant growth was very sensitive to the high temperature 42°C in contrast to the WT or the snf6/Tet-SNF6 strain without doxycycline treatment (Fig. 4A). When grown at alkaline pH (Fig. 4B), the snf6 mutant was completely unable to proliferate at the high temperature 42°C compared to the other temperatures of 30°C and 37°C.
Transcriptional profiling and genome-wide occupancy of Snf6 under hyphapromoting conditions. Given its critical role in hypha formation, Snf6 might be required to control, at the chromatin level, the transcription of genes that promote morphogenesis in C. albicans. To assess this, the genomic occupancy of Snf6 was determined under conditions that stimulate hyphal growth (10% FBS, 37°C). Snf6 bound 648 promoter regions (854 and 814 peaks were detected in both replicates), which correspond to approximately 10% of C. albicans genes. A total of 196 promoters occupied by Snf6 were common with the yeast condition and were enriched in genes related to carbohydrate metabolism ( Fig. 5A; Table S4). Promoters that were bound specifically under hyphal conditions were associated with different biological processes such as respiration, vesicle transport, mating, and ribosome biogenesis, while those that were unique to the yeast growth condition were mainly enriched in oxidoreduction coenzymes (Fig. 5A). Overall, compared to the yeast growth condition results, these data show that Snf6 expands its binding to include other sets of genes implicated in other biological processes that are involved in the hyphal transcriptional program. Interestingly, Snf6 occupied the promoter of the key transcriptional repressor of hyphal formation, Nrg1, specifically under yeast-promoting conditions.
Similarly to the yeast growth condition experiments, we used microarray profiling to identify transcripts that depend on Snf6 for their modulation during the yeast-to-hypha transition. We focused our analysis in genes that simultaneously were direct targets of Snf6 and were differentially expressed in the snf6 conditional mutant under repressible conditions. Snf6 was required to activate genes related to oxidative stress response, drug and hexose transport, and diverse metabolic processes such as lipid and glutamine biosynthesis ( Fig. 5B; Table S5). As was seen during yeast-form growth, Snf6 can behave as a repressor of metabolic genes, including carbohydrate, amino acid, and lipid metabolic genes (Fig. 5B). Although Snf6 was essential for hyphal formation, no binding was found at the promoters of hypha-specific genes, such as HWP1, ECE1, SOD5, ALS3, and RBT4, suggesting that Snf6 or the SWI/SNF complex might control filamentation indirectly through another transcriptional regulator. However, Snf6 binds a large number of members of the FGR (filamentous growth regulator) family (FGR6-1, FGR10,  FGR6-3, FGR3, FGR50, FGR6-10, FGR42, FGR51, and GPI19), as well as genes for cell adhesion factors (ALS1, TDH3, and DEF1) and cell separation regulator genes, such as ACE2 and ENG1.
GSEAs of the upregulated genes in the mutant under hyphal growth conditions show enrichment in genes downregulated in hyphae and biofilm and a correlation with Tbf1, Fhl1, and Ifh1 transcription factor binding. However, the set of downregulated genes was enriched in genes that were identified to be upregulated during gut intestinal colonization (21), suggesting a potential role of Snf6 in the regulation of gastrointestinal (GI) colonization and dissemination.

DISCUSSION
This study represents a comprehensive characterization, at the genomic level, of the role of the SWI/SNF complex in the pathogenic yeast C. albicans. So far, the C. albicans SWI/SNF complex has been implicated in morphogenesis (11) and drug resistance (12) without a focus on its general function on transcriptional regulation at the genomewide level. We have shown that an SWI/SNF complex subunit, Snf6, was required for both metabolic flexibility and invasive growth, which are key features needed for an opportunistic pathogen such as C. albicans to maintain its fitness and pathogenicity inside its host. Snf6 was required for C. albicans to utilize different carbon sources, suggesting a pivotal role of this SWI/SNF subunit in carbon metabolic flexibility. Additionally, Snf6 was also required to resist heat stress. Our data suggest a direct transcriptional control of carbohydrate utilization genes as well as heat shock factor genes by Snf6. Surprisingly however, those genes were activated in the snf6 mutant rather than being downregulated. A similar trend was observed in S. cerevisiae, where glycolytic genes were upregulated in an snf6 (9) or snf5 (10) mutant. This phenomenon might be explained by the fact that fungal cells could compensate for the loss of SWI/SNF activity by recruiting other chromatin remodelers to mediate the transcriptional activation of carbohydrate or heat shock genes.
Although Snf2, the catalytic subunit of the SWI/SNF complex, and the other core proteins are conserved among eukaryotes, Snf6 is one of the components of the fungal SWI/SNF complex that is not present in the counterpart human complex. Although fungus specific, Snf6 is exclusively present in the hemiascomycetes clade, and even within this phylogenetic group and with the exception of the short region at the N-terminal ends (Fig. 1A), the Snf6 protein sequence is highly divergent. Snf6 protein has no specifically identified functional domain, which suggests that this subunit might play a structural role important for the integrity of the SWI/SNF complex, rather than providing a catalytic function. Indeed, Snf6 was shown to be required for both the structural integrity and DNA-binding activity of the SWI/SNF complex in yeast (10,22,23). Recent investigations have shown that the Snf6 subunit interacts with the helicase/ SANT-associated (HSA) domain of the catalytic subunit Snf2 (10). Interestingly, this interaction is mediated by the N-terminal conserved region of Snf6 that we have identified here as representing the only conserved part of the protein. The Snf2 HSA domain represents a binding platform for the actin-related proteins Arp7 and Arp9, and it is essential for the chromatin-remodeling activity (24).
Our TAP-MS experiment showed that Snf6 interacts with Sth1, which is the catalytic ATPase subunit of the chromatin-remodeling complex RSC (25). This suggests that Snf6 might be a shared subunit between these two functionally homologous complexes. In the budding yeast, Snf6 is a unique subunit of SWI/SNF, in contrast to Rtt102, Arp7, and Arp9, which are shared with RSC (26,27). In the fission yeast and metazoans, SWI/SNF and RSC complexes share more than 6 subunits, a much greater degree of overlap than in S. cerevisiae (28). An Snf6-Sth1 interaction in C. albicans could suggest the possibility that SWI/SNF and RSC complexes might contribute together to chromatin remodeling at common promoters and thus could show functional redundancy. In S. cerevisiae, such redundancy was previously reported where RSC and SWI/SNF cooperate with each other in histone eviction at the promoters of heat shock proteins (29).
Similarly, the role of Snf6 in morphogenesis might be mediated through its recruitment by a transcriptional activator or repressor to control the yeast-to-hypha genetic program. Given the consistent number of transcriptional regulators that control this essential virulence trait in C. albicans, it is challenging to predict those that might use the SWI/SNF complex. Of note, under hypha-promoting conditions, Snf6 was not found to occupy promoters of key hypha-specific genes, such as HWP1 and ECE1, suggesting that the candidate transcription regulator is an indirect regulator of either those genes or higher-hierarchy regulators of other direct transcriptional regulators. Interestingly, a direct target that Snf6 fails to repress during filamentation was the yeast-specific cell wall protein, Ywp1. This suggests that Snf6 is needed to suppress the morphological yeast-specific transcriptional program when C. albicans cells undergo the yeast-tohypha transition. Furthermore, the Nrg1 promoter was bound exclusively under yeast conditions, which suggests that Snf6 might contribute to the activation of this yeastpromoting transcriptional regulator (30), and when C. albicans switches to the filamentous form, Snf6 might release the promoter of Nrg1 to mediate the derepression of hypha-specific genes.
Since Snf6 has no obvious catalytic activity to be used as biochemical readout to screen for such inhibitors, it may be challenging to set up a high-throughput drug discovery routine. In S. cerevisiae, Snf6 is required for the maintaining the full structural integrity of SWI/SNF (9,31). Assuming that this function is conserved in C. albicans, an alternative approach to chemically compromise Snf6 function would be identification of small molecules that might dissociate Snf6 from the rest of the SWI/SNF complex. In contrast to Snf6, the fungus-specific SWI/SNF subunits Snf11 and Swp82 were present in the S. cerevisiae, C. glabrata, and Kluyveromyces lactis lineage but absent from the CTG clade and euascomycetes (Fig. 6). Given the role of SWI/SNF in C. glabrata biofilm formation (15), chemical dissociation of those subunits could be also be applied to manage infections caused by this resistant growth state. Recently, an increased focus on the druggability of protein-protein interaction has led to identification of potential drugs that reached clinical development (32); however, such an approach has not yet been exploited for antimicrobial discovery. This concept could also be applied to the other fungus-specific SWI/SNF subunits.
We have shown that Snf6 binds directly to gene promoters to mediate both shown were identified from studies in the yeast models S. cerevisiae (48) and S. pombe (28). Subunits from other fungi were identified based on sequence similarity using Blast analysis. The topology of the phylogenetic tree was inspired by reference 49.
transcriptional activation and repression. This feature is preserved in the SWI/SNF complex of S. cerevisiae, Schizosaccharomyces pombe, and mammals (14,28,(33)(34)(35). This underlines the point that both transcriptional activators and repressors recruit the SWI/SNF to their target promoters. For instance, in C. albicans, carbohydrate and glycolytic genes might be transcriptionally controlled either by activators such as the transcription factors Tye7 and Gal4 (36)(37)(38) and Ace2 (39) or by repressors such as Mig1 (40) or Rgt1 (41). All these transcriptional regulators have been shown to play a critical role in host colonization and invasion, and their physical interactions with Snf6 or other subunits of the SWI/SNF complex represent potential therapeutic interfaces to target with small molecules. The feasibility of such an approach has been elegantly demonstrated in C. glabrata, where small molecules that disrupt interaction between the drug resistance regulator, Pdr1, and the mediator complex abolished drug resistance in clinical isolates (42). Thus, in addition to targeting protein-protein interactions within the SWI/SNF complex, transcriptional activator/repressor-SWI/SNF interactions represent additional candidates for antifungal therapeutic strategies.

MATERIALS AND METHODS
Yeast strains and growth conditions. Strains used in this study are listed in Table S6 in the supplemental material. For general propagation and maintenance, the strains were cultured at 30°C in yeast extract-peptone-dextrose (YPD) medium supplemented with uridine (2% Bacto peptone, 1% yeast extract, 2% dextrose, and 50 g/ml uridine, with the addition of 2% agar for solid medium). Cell growth, transformation, and DNA preparation were carried out using standard yeast procedures.
For gene expression profiling under yeast-promoting conditions, cells were collected directly from agar plates with or without doxycycline (40 g/ml) after growing for 48 h at 30°C. For the hyphal form, cells were harvested from an agar plate with 10% FBS with or without doxycycline after 48 h at 37°C. Harvested cells were rapidly frozen in liquid nitrogen and immediately processed for RNA extraction.
Snf6 GRACE mutant phenotyping. To promote hyphal growth, C. albicans cells were serially diluted and spotted onto a plate of YPD agar containing 10% FBS with or without 40 g/ml doxycycline. Plates were then incubated for 3 to 4 days at 37°C. To assess the metabolic flexibility of the snf6 conditional mutant on different carbon sources, cells were plated on YP agar medium containing the appropriate carbon source (glucose, galactose, fructose, mannose, or glycerol) at 2%. Cells were grown at 30°C for 3 days.
RNA extraction and microarray experiment. To extract RNA from C. albicans cells, samples stored at Ϫ80°C were placed on ice, and RNeasy buffer RLT was added to pellets at a buffer/pellet ratio of 10:1 (vol/vol). The pellet was allowed to thaw in the buffer with vortexing briefly at high speed. The resuspended pellet was placed back on ice and divided into 1-ml aliquots in 2-ml screw-cap microcentrifuge tubes containing 0.6 ml of 3-mm-diameter acid-washed glass beads. Samples were homogenized 5 times, for 1 min each, at 4,200 rpm using a BeadBeater homogenizer. Samples were placed on ice for 1 min after each homogenization step. Next, the Qiagen RNeasy protocol was followed as recommended by the supplier. Total RNA samples were eluted in RNase-free H 2 O. RNA quality and integrity were assessed using an Agilent 2100 Bioanalyzer.
cDNA labeling and microarray production were performed as previously described (43). Briefly, 20 g of total RNA was reverse transcribed using 9 ng of oligo(dT) 21 and 15 ng of random octamers (Invitrogen) in the presence of Cy3 or Cy5-dCTP (Invitrogen) and 400 U of Superscript III reverse transcriptase (Invitrogen). After cDNA synthesis, template RNA was degraded by adding 2.5 U RNase H (Promega, Madison, WI) and 1 g RNase A (Pharmacia, Uppsala, Sweden) followed by incubation for 20 min at 37°C. The labeled cDNAs were purified with a QIAquick PCR purification kit (Qiagen). Prior to hybridization, Cy3/Cy5-labeled cDNA was quantified using an ND-1000 UV-visible (UV-Vis) spectrophotometer (Nano-Drop, Wilmington, DE) to confirm dye incorporation. DNA microarrays were processed and analyzed as previously described (44).
Whole-genome location profiling by ChIP-chip and data analysis. SNF6 (ORF19.831) was TAP tagged in vivo with a TAP-URA3 PCR product as previously described (45). Transformants were selected on SC-Ura plates, and correct integration of the TAP tag was checked by PCR and Western blotting. The Snf6-TAP fusion was fully functional since deleting the nontagged allele in this strain revealed phenotypes comparable to the parental strain (SN148) under all growth conditions investigated in the current work (data not shown). Cells were grown to an optical density at 600 nm (OD 600 ) of 2 in 40 ml of YPD. The subsequent steps of DNA cross-linking, DNA shearing, chromatin immunoprecipitation, and DNA labeling with Cy dyes were conducted exactly as described by Lavoie et al. (45). Tiling arrays were cohybridized with tagged immunoprecipitated (Cy5-labeled) and mock-immunoprecipitated (untagged SN148 strain; Cy3-labeled) DNA samples. Microarray hybridization, washing, and scanning were performed as described by Sellam et al. (44). The significance cutoff was determined using the distribution of log ratios for each factor. It was set at 2 standard deviations from the mean of log-transformed fold enrichments. Values shown are of two biological replicates derived from independently isolated transformants of tagged and mock constructs. Peak detection was performed using Gaussian edge detection applied to the smoothed probe signal curve as previously described (46).
Tiling arrays were designed as previously described (47). Briefly, starting from sequences from the C. albicans Genome Assembly 21 and the MTL alpha locus, we extracted a continuous series of 242,860 60-bp oligonucleotides, each overlapping by 1 bp. We then eliminated 2,062 probes containing stretches of 13 or more A or T nucleotides. The remaining 240,798 sequences were then used to produce sense (Watson strand) and antisense (Crick strand) whole-genome tiling arrays using the Agilent Technologies eArray platform.
Immunoblotting and coimmunoprecipitation. C. albicans Snf6-TAP and other double-tagged strains (Table S6) were grown to mid-log phase in YPD medium. Cells at a final OD 600 of 1 to 1.5 were harvested by centrifugation and lysed by bead beating in IP150 buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 2 mM MgCl 2 , 0.1% Nonidet P-40) supplemented with a Complete Mini protease inhibitor mixture tablet (Roche Applied Science) and 1 mM phenylmethylsulfonyl fluoride (PMSF). The lysates were then cleared by centrifugation, and protein concentration was estimated using the Bradford assay. One milligram of total protein was added to 50 l of anti-tap IgG Sepharose beads (GE), monoclonal mouse anti-Myc (9E10), or antihemagglutinin (anti-HA) (12CA5) (Roche Applied Science) and incubated at 4°C with end-over-end mixing overnight. The next morning, beads were centrifuged at 2,000 rpm at 4°C, washed three times with IP150 buffer, boiled with SDS-PAGE loading buffer, and resolved by 4 to 20% gradient SDS-PAGE. Proteins were transferred onto a nitrocellulose membrane and analyzed by Western blotting using rabbit anti-TAP polyclonal antibody (1:2,500) (GenScript), rabbit anti-Myc (1:1,000) (Santa Cruz Biotechnology), or anti-HA (1:2,500) (Roche Applied Science) wherever applicable.
TAPs and liquid chromatography-tandem mass spectrometry (LC-MS/MS). To assess proteinprotein interactions on a large scale, we used an Snf6 TAP tag construct. Tandem affinity purifications were performed as described at the website http://depts.washington.edu/yeastrc/pages/plasmids.html and then precipitated with trichloroacetic acid (TCA) as described by Tebbji et al. (47). The mass spectrometer used was the Velos LTQ-Orbitrap (Thermo Fisher, San Jose, CA). Raw mass spectrometric data were processed using Proteome Discoverer 1.3. Spectra were searched against a C. albicans SC5314 database obtained from http://www.candidagenome.org containing 6,215 protein sequence entries.
Data availability. Raw and processed microarray and ChIP-chip data have been submitted to the GEO database under accession no. GSE106278. The averages of all gene expression of the snf6 mutant in yeast and hyphae are provided in Supplemental Tables S3 and S5 (sheets named "All genes value"). All raw data regarding the peaks of Snf6 binding are in Supplemental Tables S2 and S4 (sheets named "Snf6 peaks").

ACKNOWLEDGMENTS
We are grateful to Hervé Hogues for assistance and help with the ChIP-chip data processing and Merck and Genome Canada for making the GRACE strains available to the academic research community. Thanks also to members of the microarray facility at NRC, especially André Nantel, and special thanks to Marcos Di Falco from the Tsang lab at Concordia University and Tuana Mesquita for their help with mass spectrometry and Julien Richard Albert for phenotype assistance.